STOCK TITAN

[Form 4] Acuren Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 highlights: Acuren Corp. (TIC) director Dickerson Wright reported the conversion and acquisition of Acuren common shares on 08/04/2025 following the closing of the NV5 Global merger. In exchange for 13,328 NV5 shares and 157,716 vested NV5 RSAs, Mr. Wright received the merger consideration of 1.1523 TIC shares plus $10 cash per NV5 share.

Indirect ownership: Nine family trusts now hold between 480.7k-2.30m shares each, bringing Wright’s indirect beneficial stake to roughly 8.0 million TIC shares. Wright disclaims beneficial ownership beyond his pecuniary interest but exercises voting and investment power as trustee.

Direct ownership: 9,524 restricted stock units were granted on 08/04/2025; they vest one year later and will settle in an equal number of TIC shares. No shares were disposed of.

Post-transaction, Wright’s economic exposure to Acuren materially increases, aligning his interests with shareholders as the combined entity begins trading.

Punti salienti del Modulo 4: Il direttore di Acuren Corp. (TIC), Dickerson Wright, ha segnalato la conversione e acquisizione di azioni ordinarie Acuren il 04/08/2025, a seguito della chiusura della fusione con NV5 Global. In cambio di 13.328 azioni NV5 e 157.716 RSA NV5 maturate, il signor Wright ha ricevuto la controparte della fusione pari a 1,1523 azioni TIC più 10 dollari in contanti per ogni azione NV5.

Proprietà indiretta: Nove trust familiari detengono ora tra 480.700 e 2.300.000 azioni ciascuno, portando la quota indiretta di Wright a circa 8,0 milioni di azioni TIC. Wright rinuncia alla proprietà beneficiaria oltre il suo interesse pecuniario, ma esercita il potere di voto e di investimento in qualità di fiduciario.

Proprietà diretta: Il 04/08/2025 sono state assegnate 9.524 unità di azioni vincolate; maturano un anno dopo e saranno regolate con un numero equivalente di azioni TIC. Non sono state cedute azioni.

Dopo la transazione, l'esposizione economica di Wright verso Acuren aumenta significativamente, allineando i suoi interessi con quelli degli azionisti mentre la società combinata inizia la negoziazione.

Aspectos destacados del Formulario 4: El director de Acuren Corp. (TIC), Dickerson Wright, informó sobre la conversión y adquisición de acciones comunes de Acuren el 04/08/2025 tras el cierre de la fusión con NV5 Global. A cambio de 13,328 acciones de NV5 y 157,716 RSA de NV5 adquiridas, el Sr. Wright recibió la contraprestación de la fusión de 1.1523 acciones TIC más 10 dólares en efectivo por cada acción NV5.

Propiedad indirecta: Nueve fideicomisos familiares ahora poseen entre 480.7k y 2.30 millones de acciones cada uno, llevando la participación indirecta beneficiaria de Wright a aproximadamente 8.0 millones de acciones TIC. Wright renuncia a la propiedad beneficiaria más allá de su interés pecuniario pero ejerce el poder de voto e inversión como fideicomisario.

Propiedad directa: Se otorgaron 9,524 unidades de acciones restringidas el 04/08/2025; se consolidan un año después y se liquidarán en un número igual de acciones TIC. No se dispusieron acciones.

Tras la transacción, la exposición económica de Wright a Acuren aumenta significativamente, alineando sus intereses con los de los accionistas mientras la entidad combinada comienza a cotizar.

Form 4 주요 내용: Acuren Corp.(TIC) 이사 Dickerson Wright는 2025년 8월 4일 NV5 Global 합병 완료 후 Acuren 보통주 전환 및 취득을 보고했습니다. 13,328 NV5 주식과 157,716 NV5 RSAs(확정된 주식)와 교환하여 Wright 씨는 합병 대가로 NV5 주식당 1.1523 TIC 주식과 현금 10달러를 받았습니다.

간접 소유: 9개의 가족 신탁이 각각 48만 7000주에서 230만 주 사이를 보유하여 Wright의 간접 수익 지분이 약 800만 TIC 주식에 이릅니다. Wright는 금전적 이익을 초과하는 수익 소유권을 부인하지만, 수탁자로서 의결권과 투자 권한을 행사합니다.

직접 소유: 2025년 8월 4일에 9,524개의 제한 주식 단위가 부여되었으며, 1년 후에 확정되어 동일한 수의 TIC 주식으로 정산됩니다. 주식 처분은 없었습니다.

거래 후 Wright의 Acuren에 대한 경제적 노출이 크게 증가하여, 합병된 회사가 거래를 시작함에 따라 주주들과 이해관계가 일치하게 됩니다.

Points clés du formulaire 4 : Dickerson Wright, administrateur d'Acuren Corp. (TIC), a déclaré la conversion et l'acquisition d'actions ordinaires Acuren le 04/08/2025 suite à la clôture de la fusion avec NV5 Global. En échange de 13 328 actions NV5 et 157 716 RSA NV5 acquises, M. Wright a reçu la contrepartie de la fusion de 1,1523 actions TIC plus 10 $ en espèces par action NV5.

Propriété indirecte : Neuf trusts familiaux détiennent désormais entre 480 700 et 2,3 millions d'actions chacun, portant la participation indirecte bénéficiaire de Wright à environ 8,0 millions d'actions TIC. Wright décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire mais exerce le pouvoir de vote et d'investissement en tant que fiduciaire.

Propriété directe : 9 524 unités d'actions restreintes ont été attribuées le 04/08/2025 ; elles seront acquises un an plus tard et réglées en un nombre égal d'actions TIC. Aucune action n'a été cédée.

Après la transaction, l'exposition économique de Wright à Acuren augmente considérablement, alignant ses intérêts sur ceux des actionnaires alors que l'entité combinée commence à être cotée.

Formular 4 Highlights: Dickerson Wright, Direktor von Acuren Corp. (TIC), meldete am 04.08.2025 die Umwandlung und den Erwerb von Acuren-Stammaktien nach dem Abschluss der NV5 Global Fusion. Im Austausch für 13.328 NV5-Aktien und 157.716 unverfallbare NV5-RSAs erhielt Herr Wright die Fusionsgegenleistung von 1,1523 TIC-Aktien plus 10 USD in bar pro NV5-Aktie.

Indirekter Besitz: Neun Familienstiftungen halten nun jeweils zwischen 480.700 und 2,30 Millionen Aktien, was Wrights indirekten wirtschaftlichen Anteil auf etwa 8,0 Millionen TIC-Aktien erhöht. Wright lehnt eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus ab, übt jedoch als Treuhänder Stimm- und Investitionsrechte aus.

Direkter Besitz: Am 04.08.2025 wurden 9.524 Restricted Stock Units gewährt; diese werden ein Jahr später fällig und werden in einer gleichen Anzahl von TIC-Aktien beglichen. Es wurden keine Aktien veräußert.

Nach der Transaktion steigt Wrights wirtschaftliche Beteiligung an Acuren erheblich, wodurch seine Interessen mit denen der Aktionäre übereinstimmen, während das kombinierte Unternehmen den Handel aufnimmt.

Positive
  • ~8 million TIC shares moved under Wright-controlled trusts, increasing insider alignment with shareholders.
  • No shares sold; all activity stems from merger conversion, signalling long-term holding intent.
Negative
  • None.

Insights

TL;DR: Wright’s family trusts gained ~8 m TIC shares via merger conversion; alignment positive but routine for closing.

The filing documents share issuance tied to the NV5–Acuren merger, not an open-market purchase. Although the absolute number (≈8 m shares plus 9,524 RSUs) seems large, it reflects automatic conversion, so cash outlay is zero and market-signal value is modest. Still, Wright’s enlarged stake strengthens long-term incentive alignment. No dispositions, option exercises, or sales limits downside concern. Impact on float is already embedded in merger terms; therefore, the disclosure is governance-neutral rather than market-moving.

Punti salienti del Modulo 4: Il direttore di Acuren Corp. (TIC), Dickerson Wright, ha segnalato la conversione e acquisizione di azioni ordinarie Acuren il 04/08/2025, a seguito della chiusura della fusione con NV5 Global. In cambio di 13.328 azioni NV5 e 157.716 RSA NV5 maturate, il signor Wright ha ricevuto la controparte della fusione pari a 1,1523 azioni TIC più 10 dollari in contanti per ogni azione NV5.

Proprietà indiretta: Nove trust familiari detengono ora tra 480.700 e 2.300.000 azioni ciascuno, portando la quota indiretta di Wright a circa 8,0 milioni di azioni TIC. Wright rinuncia alla proprietà beneficiaria oltre il suo interesse pecuniario, ma esercita il potere di voto e di investimento in qualità di fiduciario.

Proprietà diretta: Il 04/08/2025 sono state assegnate 9.524 unità di azioni vincolate; maturano un anno dopo e saranno regolate con un numero equivalente di azioni TIC. Non sono state cedute azioni.

Dopo la transazione, l'esposizione economica di Wright verso Acuren aumenta significativamente, allineando i suoi interessi con quelli degli azionisti mentre la società combinata inizia la negoziazione.

Aspectos destacados del Formulario 4: El director de Acuren Corp. (TIC), Dickerson Wright, informó sobre la conversión y adquisición de acciones comunes de Acuren el 04/08/2025 tras el cierre de la fusión con NV5 Global. A cambio de 13,328 acciones de NV5 y 157,716 RSA de NV5 adquiridas, el Sr. Wright recibió la contraprestación de la fusión de 1.1523 acciones TIC más 10 dólares en efectivo por cada acción NV5.

Propiedad indirecta: Nueve fideicomisos familiares ahora poseen entre 480.7k y 2.30 millones de acciones cada uno, llevando la participación indirecta beneficiaria de Wright a aproximadamente 8.0 millones de acciones TIC. Wright renuncia a la propiedad beneficiaria más allá de su interés pecuniario pero ejerce el poder de voto e inversión como fideicomisario.

Propiedad directa: Se otorgaron 9,524 unidades de acciones restringidas el 04/08/2025; se consolidan un año después y se liquidarán en un número igual de acciones TIC. No se dispusieron acciones.

Tras la transacción, la exposición económica de Wright a Acuren aumenta significativamente, alineando sus intereses con los de los accionistas mientras la entidad combinada comienza a cotizar.

Form 4 주요 내용: Acuren Corp.(TIC) 이사 Dickerson Wright는 2025년 8월 4일 NV5 Global 합병 완료 후 Acuren 보통주 전환 및 취득을 보고했습니다. 13,328 NV5 주식과 157,716 NV5 RSAs(확정된 주식)와 교환하여 Wright 씨는 합병 대가로 NV5 주식당 1.1523 TIC 주식과 현금 10달러를 받았습니다.

간접 소유: 9개의 가족 신탁이 각각 48만 7000주에서 230만 주 사이를 보유하여 Wright의 간접 수익 지분이 약 800만 TIC 주식에 이릅니다. Wright는 금전적 이익을 초과하는 수익 소유권을 부인하지만, 수탁자로서 의결권과 투자 권한을 행사합니다.

직접 소유: 2025년 8월 4일에 9,524개의 제한 주식 단위가 부여되었으며, 1년 후에 확정되어 동일한 수의 TIC 주식으로 정산됩니다. 주식 처분은 없었습니다.

거래 후 Wright의 Acuren에 대한 경제적 노출이 크게 증가하여, 합병된 회사가 거래를 시작함에 따라 주주들과 이해관계가 일치하게 됩니다.

Points clés du formulaire 4 : Dickerson Wright, administrateur d'Acuren Corp. (TIC), a déclaré la conversion et l'acquisition d'actions ordinaires Acuren le 04/08/2025 suite à la clôture de la fusion avec NV5 Global. En échange de 13 328 actions NV5 et 157 716 RSA NV5 acquises, M. Wright a reçu la contrepartie de la fusion de 1,1523 actions TIC plus 10 $ en espèces par action NV5.

Propriété indirecte : Neuf trusts familiaux détiennent désormais entre 480 700 et 2,3 millions d'actions chacun, portant la participation indirecte bénéficiaire de Wright à environ 8,0 millions d'actions TIC. Wright décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire mais exerce le pouvoir de vote et d'investissement en tant que fiduciaire.

Propriété directe : 9 524 unités d'actions restreintes ont été attribuées le 04/08/2025 ; elles seront acquises un an plus tard et réglées en un nombre égal d'actions TIC. Aucune action n'a été cédée.

Après la transaction, l'exposition économique de Wright à Acuren augmente considérablement, alignant ses intérêts sur ceux des actionnaires alors que l'entité combinée commence à être cotée.

Formular 4 Highlights: Dickerson Wright, Direktor von Acuren Corp. (TIC), meldete am 04.08.2025 die Umwandlung und den Erwerb von Acuren-Stammaktien nach dem Abschluss der NV5 Global Fusion. Im Austausch für 13.328 NV5-Aktien und 157.716 unverfallbare NV5-RSAs erhielt Herr Wright die Fusionsgegenleistung von 1,1523 TIC-Aktien plus 10 USD in bar pro NV5-Aktie.

Indirekter Besitz: Neun Familienstiftungen halten nun jeweils zwischen 480.700 und 2,30 Millionen Aktien, was Wrights indirekten wirtschaftlichen Anteil auf etwa 8,0 Millionen TIC-Aktien erhöht. Wright lehnt eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus ab, übt jedoch als Treuhänder Stimm- und Investitionsrechte aus.

Direkter Besitz: Am 04.08.2025 wurden 9.524 Restricted Stock Units gewährt; diese werden ein Jahr später fällig und werden in einer gleichen Anzahl von TIC-Aktien beglichen. Es wurden keine Aktien veräußert.

Nach der Transaktion steigt Wrights wirtschaftliche Beteiligung an Acuren erheblich, wodurch seine Interessen mit denen der Aktionäre übereinstimmen, während das kombinierte Unternehmen den Handel aufnimmt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WRIGHT DICKERSON

(Last) (First) (Middle)
C/O ACUREN CORPORATION
14434 MEDICAL COMPLEX DRIVE, SUITE 100

(Street)
TOMBALL TX 77377

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACUREN CORP [ TIC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/04/2025 A(1) 2,301,994 A (1) 2,301,994(1) I Wright Family Trust dated December 12, 1990(2)
Common Stock 08/04/2025 A(1) 683,701 A (1) 683,701(1) I The Lauren Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 944,148 A (1) 944,148(1) I The Lauren Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 480,702 A (1) 480,702(1) I The Lauren Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 683,701 A (1) 683,701(1) I The Stephanie Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 741,150 A (1) 741,150(1) I The Stephanie Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 944,148 A (1) 944,148(1) I The Stephanie Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 480,702 A (1) 480,702(1) I The Stephanie Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock 08/04/2025 A(1) 741,150 A (1) 741,150(1) I The Lauren Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 08/04/2025 A 9,524 (4) (4) Common Stock 9,524 $0.00 9,524 D
Explanation of Responses:
1. On August 4, 2025, as a result of the mergers contemplated by that certain Agreement and Plan of Merger, dated as of May 14, 2025, by and among the Issuer, NV5 Global, Inc. ("NV5"), Ryder Merger Sub I and Ryder Merger Sub II (the "Merger Agreement"), 13,328 shares of common stock of NV5 and 157,716 restricted stock awards of NV5 (which were vested in full in accordance with their terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings)were converted into the right to receive 1.1523 shares of the Issuer's common stock ("Common Stock") per share, and $10.00 in cash per share, without interest (collectively, the "Merger Consideration"). Pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers.
2. Dickerson Wright and his wife, Katherine Wright, are trustees. As a trustee, the Reporting Person may be deemed to exercise voting and investment power over the shares held by each trust. Mr. Wright disclaims beneficial ownership of these securities except to the extent of this pecuniary interest therein.
3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
4. These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date).
/s/ MaryJo Obrien, Attorney-in-Fact 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Acuren (TIC) shares did Dickerson Wright acquire?

Trusts controlled by Wright received about 8.0 million shares; he also received 9,524 RSUs that vest in 2026.

Was cash paid for the newly reported shares?

No. Shares were issued automatically from the NV5 merger conversion with no additional cash outlay by Wright.

What is the vesting schedule for the 9,524 RSUs?

The RSUs vest on 08/04/2026, one year from the grant date.

Does the filing indicate any share sales by the insider?

No. No dispositions were reported; all transactions were coded "A" for acquisition.

Why were NV5 shares converted into Acuren shares?

The conversion terms stem from the May 14 2025 Merger Agreement between Acuren, NV5, and related merger subsidiaries.
Acuren Corp

NYSE:TIC

TIC Rankings

TIC Latest News

TIC Latest SEC Filings

TIC Stock Data

1.99B
100.58M
15.88%
83.3%
6.96%
Specialty Business Services
Services-business Services, Nec
Link
United States
TOMBALL